Works matching IS 25233548 AND DT 2022 AND VI 42 AND IP 12

Results: 14

Sintilimab versus docetaxel as second‐line treatment in advanced or metastatic squamous non‐small‐cell lung cancer: an open‐label, randomized controlled phase 3 trial (ORIENT‐3).
Published in:
Cancer Communications, 2022, v. 42, n. 12, p. 1314, doi. 10.1002/cac2.12385
By:
- Shi, Yuankai;
- Wu, Lin;
- Yu, Xinmin;
- Xing, Puyuan;
- Wang, Yan;
- Zhou, Jianying;
- Wang, Airong;
- Shi, Jianhua;
- Hu, Yi;
- Wang, Ziping;
- An, Guangyu;
- Fang, Yong;
- Sun, Sanyuan;
- Zhou, Caicun;
- Wang, Changli;
- Ye, Feng;
- Li, Xingya;
- Wang, Junye;
- Wang, Mengzhao;
- Liu, Yunpeng
Publication type:
Article
Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy.
Published in:
Cancer Communications, 2022, v. 42, n. 12, p. 1331, doi. 10.1002/cac2.12383
By:
- Wu, Fengying;
- Jiang, Tao;
- Chen, Gongyan;
- Huang, Yunchao;
- Zhou, Jianying;
- Lin, Lizhu;
- Feng, Jifeng;
- Wang, Zhehai;
- Shu, Yongqian;
- Shi, Jianhua;
- Hu, Yi;
- Wang, Qiming;
- Cheng, Ying;
- Chen, Jianhua;
- Lin, Xiaoyan;
- Wang, Yongsheng;
- Huang, Jianan;
- Cui, Jiuwei;
- Cao, Lejie;
- Liu, Yunpeng
Publication type:
Article
Lymphatic metastasis in non‐small cell lung cancer: recent discoveries and novel therapeutic targets.
Published in:
Cancer Communications, 2022, v. 42, n. 12, p. 1403, doi. 10.1002/cac2.12378
By:
- Diao, Xiayao;
- Guo, Chao;
- Li, Shanqing
Publication type:
Article
Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long‐term clinical outcomes and health‐related quality of life assessment.
Published in:
Cancer Communications, 2022, v. 42, n. 12, p. 1387, doi. 10.1002/cac2.12376
By:
- Yan, Chen‐hua;
- Wang, Yu;
- Sun, Yu‐qian;
- Cheng, Yi‐fei;
- Mo, Xiao‐dong;
- Wang, Feng‐rong;
- Chen, Yu‐hong;
- Zhang, Yuan‐yuan;
- Han, Ting‐ting;
- Chen, Huan;
- Xu, Lan‐ping;
- Zhang, Xiao‐hui;
- Liu, Kai‐yan;
- Huang, Xiao‐jun
Publication type:
Article
The diagnosis, classification, and treatment of sarcoma in this era of artificial intelligence and immunotherapy.
Published in:
Cancer Communications, 2022, v. 42, n. 12, p. 1288, doi. 10.1002/cac2.12373
By:
- Crombé, Amandine;
- Roulleau‐Dugage, Mathtieu;
- Italiano, Antoine
Publication type:
Article
Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
Published in:
Cancer Communications, 2022, v. 42, n. 12, p. 1367, doi. 10.1002/cac2.12372
By:
- Wu, Huanwen;
- Yu, Zicheng;
- Liu, Yueping;
- Guo, Lei;
- Teng, Lianghong;
- Guo, Lingchuan;
- Liang, Li;
- Wang, Jing;
- Gao, Jie;
- Li, Ruiyu;
- Yang, Ling;
- Nie, Xiu;
- Su, Dan;
- Liang, Zhiyong
Publication type:
Article
Current updates of CRISPR/Cas9‐mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management.
Published in:
Cancer Communications, 2022, v. 42, n. 12, p. 1257, doi. 10.1002/cac2.12366
By:
- Allemailem, Khaled S.;
- Alsahli, Mohammed A;
- Almatroudi, Ahmad;
- Alrumaihi, Faris;
- Alkhaleefah, Fahd Khaleefah;
- Rahmani, Arshad Husain;
- Khan, Amjad Ali
Publication type:
Article
N‐acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4‐acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA.
Published in:
Cancer Communications, 2022, v. 42, n. 12, p. 1347, doi. 10.1002/cac2.12363
By:
- Zheng, Xiao;
- Wang, Qi;
- Zhou, You;
- Zhang, Dachuan;
- Geng, Yiting;
- Hu, Wenwei;
- Wu, Changping;
- Shi, Yufang;
- Jiang, Jingting
Publication type:
Article
Lipid metabolism in pancreatic cancer: emerging roles and potential targets.
Published in:
Cancer Communications, 2022, v. 42, n. 12, p. 1234, doi. 10.1002/cac2.12360
By:
- Yin, Xinpeng;
- Xu, Ruiyuan;
- Song, Jianlu;
- Ruze, Rexiati;
- Chen, Yuan;
- Wang, Chengcheng;
- Xu, Qiang
Publication type:
Article
Smoking, smoking cessation, and survival after cancer diagnosis in 128,423 patients across cancer types.
Published in:
Cancer Communications, 2022, v. 42, n. 12, p. 1421, doi. 10.1002/cac2.12357
By:
- Tu, Huakang;
- Ye, Yuanqing;
- Huang, Maosheng;
- Xie, Kunlin;
- Chow, Wong‐Ho;
- Zhao, Hua;
- Wu, Xifeng
Publication type:
Article
Evaluation of immune response to anti‐COVID‐19 booster in cancer patients and chronic medical cannabis users and its association with circulating Eosinophils levels.
Published in:
Cancer Communications, 2022, v. 42, n. 12, p. 1417, doi. 10.1002/cac2.12353
By:
- Idan, Cohen;
- Salvatore, Campisi‐Pinto;
- Orit, Rozenberg;
- Ariel, Abaev;
- Marah, Khoury;
- Dana, Agbaria;
- Harel, Eitam;
- Raul, Colodner;
- Mona, Khoury;
- Hassan, Shalabna;
- Yousef, Samih;
- Camel, Mahamid;
- Mahmoud, Abu‐Amna;
- Gil, Bar‐Sela
Publication type:
Article
miR‐99a‐5p modulates doxorubicin resistance via the COX‐2/ABCG2 axis in triple‐negative breast cancer: from the discovery to in vivo studies.
Published in:
Cancer Communications, 2022, v. 42, n. 12, p. 1412, doi. 10.1002/cac2.12352
By:
- Garrido‐Cano, Iris;
- Adam‐Artigues, Anna;
- Lameirinhas, Ana;
- Blandez, Juan F.;
- Candela‐Noguera, Vicente;
- Rojo, Federico;
- Zazo, Sandra;
- Madoz‐Gúrpide, Juan;
- Lluch, Ana;
- Bermejo, Begoña;
- Sancenón, Felix;
- Cejalvo, Juan Miguel;
- Martínez‐Máñez, Ramón;
- Eroles, Pilar
Publication type:
Article
Radioimmunotherapy‐induced intratumoral changes in cervical squamous cell carcinoma at single‐cell resolution.
Published in:
Cancer Communications, 2022, v. 42, n. 12, p. 1407, doi. 10.1002/cac2.12342
By:
- Liu, Chao;
- Yu, Hao;
- Huang, Rui;
- Lei, Tianyu;
- Li, Xiaohui;
- Liu, Ming;
- Huang, Qingyu;
- Du, Qilian;
- Xing, Ligang;
- Yu, Jinming
Publication type:
Article
Issue Information.
Published in:
Cancer Communications, 2022, v. 42, n. 12, p. 1231, doi. 10.1002/cac2.12176
Publication type:
Article